Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioNTech SE ADR buy stefan

BioNTech SE ADR
Start price
€99.01
02.12.20 / 50%
Target price
€105.00
28.11.24
Performance (%)
-12.89%
Price
€86.25
17:25
Summary
This prediction is currently active. The prediction for BioNTech SE ADR disappoints with a performance of -12.89%. This prediction currently runs until 28.11.24. The prediction end date can be changed by stefan at any time. stefan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 4.015% 2.971% 16.492% 19.144%
iShares Nasdaq 100 2.755% 0.503% 40.029% 50.636%
iShares Nikkei 225® -0.826% -5.057% 14.566% 2.379%
iShares S&P 500 2.330% 0.720% 30.194% 44.181%

According to stefan what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Leading role in innovation
Strong uniques
Positive Image
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Cons
Below average Marketposition
Significant cyclical dependencies
High valuation

Comments by stefan for this prediction

In the thread Biontech SE diskutieren

Buy BioNTech SE ADR

stefan 
1
Report Share
02.12.20 Buy -12.89%
Prediction Buy
Perf. (%) -12.89%
Target price 105.000
Change
Ends at

Biontech steigert die Produktion

stefan 
1
Report Share
11.01.21

Stopped prediction by stefan for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€88.48
27.11.20
€120.00
13.34%
02.12.20

Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies
stefan 
27.11.20 50%
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€68.00
13.07.20
-
04.11.21
29.94%
27.11.20

Leading role in innovation
Strong uniques
Below average Marketposition
Significant cyclical dependencies
stefan 
13.07.20 50%